225 related articles for article (PubMed ID: 34847375)
1. Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition.
Wang F; Li S; Houerbi N; Chou TF
Cell Chem Biol; 2022 Mar; 29(3):517-529.e5. PubMed ID: 34847375
[TBL] [Abstract][Full Text] [Related]
2. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
He J; Zhu Q; Wani G; Sharma N; Wani AA
J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97.
Chauhan AK; Li P; Sun Y; Wani G; Zhu Q; Wani AA
Cell Cycle; 2021 Jan; 20(1):81-95. PubMed ID: 33381997
[TBL] [Abstract][Full Text] [Related]
4. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
5. SMER28 binding to VCP/p97 enhances both autophagic and proteasomal neurotoxic protein clearance.
Wrobel L; Hill SM; Rubinsztein DC
Autophagy; 2023 Apr; 19(4):1348-1350. PubMed ID: 36036202
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the ATPase p97/VCP: From basic research to clinical applications.
Kilgas S; Ramadan K
Cell Chem Biol; 2023 Jan; 30(1):3-21. PubMed ID: 36640759
[TBL] [Abstract][Full Text] [Related]
7. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.
Meyer H; Bug M; Bremer S
Nat Cell Biol; 2012 Feb; 14(2):117-23. PubMed ID: 22298039
[TBL] [Abstract][Full Text] [Related]
8. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
He J; Zhu Q; Wani G; Wani AA
Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
[TBL] [Abstract][Full Text] [Related]
9. COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.
Cayli S; Klug J; Chapiro J; Fröhlich S; Krasteva G; Orel L; Meinhardt A
J Biol Chem; 2009 Dec; 284(50):34944-53. PubMed ID: 19826004
[TBL] [Abstract][Full Text] [Related]
10. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
Kartal B; Alimoğulları E; Çaylı S
Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
[TBL] [Abstract][Full Text] [Related]
11. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
12. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
13. Atypical K6-ubiquitin chains mobilize p97/VCP and the proteasome to resolve formaldehyde-induced RNA-protein crosslinks.
Song W; Ramadan K
Mol Cell; 2023 Dec; 83(23):4197-4199. PubMed ID: 38065058
[TBL] [Abstract][Full Text] [Related]
14. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications.
Vij N; Fang S; Zeitlin PL
J Biol Chem; 2006 Jun; 281(25):17369-17378. PubMed ID: 16621797
[TBL] [Abstract][Full Text] [Related]
16. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
[TBL] [Abstract][Full Text] [Related]
17. Valosin-containing protein (VCP)-Adaptor Interactions are Exceptionally Dynamic and Subject to Differential Modulation by a VCP Inhibitor.
Xue L; Blythe EE; Freiberger EC; Mamrosh JL; Hebert AS; Reitsma JM; Hess S; Coon JJ; Deshaies RJ
Mol Cell Proteomics; 2016 Sep; 15(9):2970-86. PubMed ID: 27406709
[TBL] [Abstract][Full Text] [Related]
18. p97 dysfunction underlies a loss of quality control of damaged membrane proteins and promotes oxidative stress and sickling in sickle cell disease.
Song A; Wen AQ; Wen YE; Dzieciatkowska M; Kellems RE; Juneja HS; D'Alessandro A; Xia Y
FASEB J; 2022 May; 36(5):e22246. PubMed ID: 35405035
[TBL] [Abstract][Full Text] [Related]
19. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
20. NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.
Liu S; Yang H; Zhao J; Zhang YH; Song AX; Hu HY
J Biol Chem; 2013 Oct; 288(43):31339-49. PubMed ID: 24019527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
